Casdin Capital
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
7Deep-tech portfolio4 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Absci
11Co-investorsShare a portfolio company
Portfolio · 7 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Aera Therapeutics | Biotech | Active | — | — |
| Casma Therapeutics | Biotech | Active | — | — |
| Element Biosciences | Semiconductors | Active | — | — |
| Nautilus Biotechnology | Biotech | Active | — | — |
| Absci | Biotech | Public | Mar 30, 2021 | $216.0M |
| Quantum-Si | Semiconductors | Public | — | — |
| Seer Bio | Medtech | Public | — | — |
Peer ranks
Portfolio size#60
Portfolio exits#69
Raises, 12 months#88
Co-investors#158
Co-investors
- RA CapitalVenture capital3 shared
- Biomatics Capital PartnersVenture capital2 shared
- Genoa VenturesVenture capital2 shared
- Northpond VenturesVenture capital2 shared
- Agilent TechnologiesVenture capital1 shared
- ARCH VentureVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- CorningVenture capital1 shared
- DCVC BioVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
Sectors
- Biotech4
- Semiconductors2
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.